Alterity Therapeutics Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Alterity Therapeutics in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Alterity Therapeutics.

Recommendation Trends

Rating	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	1	1	1
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $8 → $12	Strong Buy	Maintains	$8 → $12	+249.85%	Jan 30, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+133.24%	Dec 12, 2024
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $4	Buy	Reiterates	$4	+16.62%	Mar 7, 2024
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Maintains $20 → $10	Strong Buy	Maintains	$20 → $10	+191.55%	Jun 5, 2023
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+483.09%	Aug 3, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 5.44M

Revenue Next Year

n/a

EPS This Year

-0.10

from -0.00

EPS Next Year

-0.10

from -0.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	4.34M	5.12M	3.92M	4.02M	5.44M	-	-
Revenue Growth	-	18.06%	-23.56%	2.63%	35.32%	-	-
EPS	-0.01	-0.01	-0.01	-0.01	-0.00	-0.10	-0.10
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.11	-0.11
Avg	-0.10	-0.10
Low	-0.10	-0.10

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.